Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era-Reference-Cited by-同舟云学术

Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era

Published:2022-01-27 Issue:5 Volume:27 Page:1749-1759
ISSN:1382-4147
Container-title:Heart Failure Reviews
language:en
Short-container-title:Heart Fail Rev

Author:

Finocchiaro Gherardo^ORCID,Magavern Emma F.,Georgioupoulos Georgios,Maurizi Niccolo’,Sinagra Gianfranco,Carr-White Gerald,Pantazis Antonis,Olivotto Iacopo

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10741-021-10198-3.pdf

Reference89 articles.

1. Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J [Internet] 29:270–276. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17916581

2. Finocchiaro G, Papadakis M, Robertus J-L, Dhutia H, Steriotis AK, Tome M, Mellor G, Merghani A, Malhotra A, Behr E, Sharma S, Sheppard MN (2016) Etiology of sudden death in sports insights from a United Kingdom Regional Registry. J Am Coll Cardiol 67

3. Stecker EC, Reinier K, Marijon E, Narayanan K, Teodorescu C, Uy-Evanado A, Gunson K, Jui J, Chugh SS (2014) Public health burden of sudden cardiac death in the United States. Circ Arrhythm Electrophysiol [Internet] 7:212–217. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24610738

4. Smith T, Jordaens L, Theuns DAMJ, van Dessel PF, Wilde AA, Hunink MGM (2013) The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis. Eur Heart J 34:211–219

5. O’Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM (2014) A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J [Internet] 35:2010–2020. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24126876

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy;International Journal of Cardiology;2024-08

2. Ultra-high field cardiac MRI in large animals and humans for translational cardiovascular research;Frontiers in Cardiovascular Medicine;2023-05-15

3. Sudden death in young athletes: Is it preventable?;European Journal of Internal Medicine;2022-10